Literature DB >> 315064

Decrease in epidermal growth factor receptor levels and production of material enhancing epidermal growth factor binding accompany the temperature-dependent changes from normal to transformed phenotype.

P Guinivan, R L Ladda.   

Abstract

Normal rat kidney (NRK) cells infected with a temperature-sensitive mutant of Kirsten sarcoma virus (Ts cells) exhibited normal monolayer morphology identical to that observed for uninfected cells (NRK cells) at the nonpermissive temperature, 39 degrees C, but grew as multilayered foci resembling NRK cells transformed by the wild-type virus (KNRK cells) at 32 degrees C, the permissive temperature. NRK cell division was stimulated by epidermal growth factor (EGF), and these cells showed high levels of EGF receptors, as determined by 125I-labeled EGF binding. KNRK cells were unresponsive to EGF and no EGF receptors were detectable. Ts cells also were unresponsive to EGF at both temperatures, but exhibited just detectable EGF binding at 32 degrees C and 10-15% of NRK cell binding at 39 degrees C. Use of EGF added to the culture medium by these cells paralleled the receptor levels. Crossfeeding experiments among NRK, KNRK, and Ts cultures indicated that Ts cells at the permissive temperature and KNRK cells at both temperatures produced a heat-stable substance(s) which stimulated DNA synthesis in NRK cells independent of the presence of serum or of EGF. Conditioned medium from the transformed cultures also significantly enhanced EGF binding to NRK cells. These studies demonstrated a correlation between the transformed phenotype and the receptor levels of a potent cell mitogen, EGF, which was readily reversible in the Ts cultures. In addition, cultures expressing the transformed phenotype produced material that did not compete for the EGF receptor but did enhance EGF binding, in contrast to other reports involving sarcoma virus-transformed cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 315064      PMCID: PMC383828          DOI: 10.1073/pnas.76.7.3377

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal.

Authors:  S COHEN
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

3.  MSA and EGF receptors on sarcoma virus transformed cells and human fibrosarcoma cells in culture.

Authors:  G J Todaro; J E De Larco; S P Nissley; M M Rechler
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

4.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

5.  Radioreceptor assay for epidermal growth factor.

Authors:  R L Ladda; L P Bullock; T Gianopoulos; L McCormick
Journal:  Anal Biochem       Date:  1979-03       Impact factor: 3.365

6.  Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth.

Authors:  D Gospodarowicz
Journal:  Nature       Date:  1974-05-10       Impact factor: 49.962

7.  Isolation of temperature-sensitive mutants of murine sarcoma virus.

Authors:  E M Scolnick; J R Stephenson; S A Aaronson
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

8.  Specific radiolabeling of a cell surface receptor for epidermal growth factor.

Authors:  M Das; T Miyakawa; C F Fox; R M Pruss; A Aharonov; H R Herschman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

9.  Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells.

Authors:  G J Todaro; J E De Larco; S Cohen
Journal:  Nature       Date:  1976-11-04       Impact factor: 49.962

10.  125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.

Authors:  G Carpenter; S Cohen
Journal:  J Cell Biol       Date:  1976-10       Impact factor: 10.539

View more
  7 in total

Review 1.  Epidermal growth factor receptors.

Authors:  E D Adamson; A R Rees
Journal:  Mol Cell Biochem       Date:  1981-02-11       Impact factor: 3.396

Review 2.  Physical-chemical principles underlying RTK activation, and their implications for human disease.

Authors:  Lijuan He; Kalina Hristova
Journal:  Biochim Biophys Acta       Date:  2011-08-05

3.  Sequential addition of platelet factor and plasma to BALB/c 3T3 fibroblast cultures stimulates somatomedin-C binding early in cell cycle.

Authors:  D R Clemmons; J J Van Wyk; W J Pledger
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

4.  Loss of epidermal growth factor receptors and release of transforming growth factors do not correlate with sarcoma virus-transformation in clonally-related NIH/3T3-derived cell lines.

Authors:  K D Brown; D M Blakeley; P Roberts; R J Avery
Journal:  Biochem J       Date:  1985-07-01       Impact factor: 3.857

5.  Epidermal growth factor receptor metabolism and protein kinase activity in human A431 cells infected with Snyder-Theilen feline sarcoma virus or harvey or Kirsten murine sarcoma virus.

Authors:  J A Cooper; E M Scolnick; B Ozanne; T Hunter
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

6.  Binding of thrombin to cultured human fibroblasts: evidence for receptor modulation.

Authors:  W M Hall; P Ganguly
Journal:  J Cell Biol       Date:  1980-12       Impact factor: 10.539

7.  Nerve growth factor-induced alteration in the response of PC12 pheochromocytoma cells to epidermal growth factor.

Authors:  K Huff; D End; G Guroff
Journal:  J Cell Biol       Date:  1981-01       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.